Recombinant Mycoplasma pneumoniae Putative type I restriction enzyme MpnORFDP M protein (MPN_342), partial

Shipped with Ice Packs
In Stock

Description

Introduction

The compound "Recombinant Mycoplasma pneumoniae Putative type I restriction enzyme MpnORFDP M protein (MPN_342), partial" refers to a recombinant protein derived from Mycoplasma pneumoniae, a pathogen causing respiratory infections. Type I restriction enzymes (R-M systems) are DNA defense mechanisms that protect bacteria from foreign genetic material. These systems typically consist of three subunits: M (modification), S (specificity), and R (restriction). While MPN_342 is not explicitly mentioned in the provided literature, insights into related type I restriction enzymes in M. pneumoniae can contextualize its potential role.

Functional Insights from Analogous Proteins

While MPN_342 remains uncharacterized, related type I restriction components in M. pneumoniae provide functional context:

Restriction-Modification Systems

  • MPN_347 and MPN_638: These proteins are part of a type I system, with MPN_347 likely involved in restriction (endonuclease activity) and MPN_638 in specificity (DNA recognition) .

  • Genomic Stability: Repetitive elements (e.g., RepMPs) in M. pneumoniae drive recombination, necessitating robust restriction systems to maintain genomic integrity .

Adhesion and Virulence Proteins

Though unrelated to restriction, proteins like P30 and P1 highlight the structural and functional diversity of M. pneumoniae surface proteins:

  • P30: Contains proline-rich repeats critical for adhesion and evasion of host immunity .

  • P1: Forms adhesion complexes with P30; mutations disrupt motility and cell binding .

Research Gaps and Future Directions

The lack of data on MPN_342 underscores gaps in understanding M. pneumoniae’s restriction machinery. Potential avenues include:

  1. Bioinformatics Analysis: Cross-referencing MPN_342 with orthologs in other Mycoplasma species.

  2. Experimental Validation: Recombinant protein expression and enzymatic assays to confirm function.

  3. Genomic Context: Mapping MPN_342’s proximity to known restriction genes (e.g., MPN_347, MPN_638) .

Product Specs

Form
Lyophilized powder. We will preferentially ship the format we have in stock. If you have special format requirements, please note them when ordering.
Lead Time
Delivery time varies depending on purchasing method and location. Consult your local distributor for specific delivery times. All proteins are shipped with normal blue ice packs by default. Request dry ice shipment in advance for an extra fee.
Notes
Avoid repeated freeze-thaw cycles. Working aliquots can be stored at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer ingredients, storage temperature, and protein stability. Liquid form shelf life is generally 6 months at -20°C/-80°C. Lyophilized form shelf life is generally 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
MPN_342; H91_orf543; MP494; Putative type I restriction enzyme MpnORFDP M protein; M.MpnORFDP; EC 2.1.1.72
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Protein Length
Partial
Purity
>85% (SDS-PAGE)
Species
Mycoplasma pneumoniae (strain ATCC 29342 / M129)
Target Names
MPN_342
Uniprot No.

Target Background

Function
Methylates specific adenine residues; required for both restriction and modification activities.
Database Links

KEGG: mpn:MPN342

Protein Families
N(4)/N(6)-methyltransferase family

Q&A

What is the MPN_342 protein and what is its role in Mycoplasma pneumoniae?

MPN_342 (MpnORFDP M protein) is a putative type I restriction enzyme that forms part of Mycoplasma pneumoniae's DNA recombination and repair machinery. M. pneumoniae possesses a limited set of approximately 11 proteins dedicated to DNA metabolism and protection . Type I restriction enzymes function as sophisticated molecular machines that protect bacteria from foreign DNA by recognizing specific DNA sequences and either cleaving unmethylated DNA (restriction) or methylating host DNA (modification) .

In M. pneumoniae, MPN_342 likely contributes to genomic integrity by participating in restriction-modification processes. These systems are critical for minimal-genome organisms like M. pneumoniae that need efficient mechanisms to maintain genetic stability despite limited genetic resources.

How does MPN_342 relate to other DNA processing proteins in M. pneumoniae?

MPN_342 appears to be functionally related to other DNA processing proteins encoded by neighboring open reading frames (ORFs). Specifically, it is located near MPN340 and MPN341, which have sequence similarity with genes encoding proteins belonging to the DNA helicase superfamily 1 (SF1) . While MPN341 has a homolog in Mycoplasma genitalium (MG244), MPN340 is M. pneumoniae-specific .

This genomic organization suggests that MPN_342 works in concert with these helicase-like proteins as part of a functional DNA processing complex. The proximity of these genes may indicate co-regulation and cooperative activity in DNA recombination, repair, or restriction-modification processes.

What are the molecular characteristics of type I restriction enzymes like MPN_342?

Type I restriction enzymes possess several distinct molecular characteristics that define their function:

  • They require S-Adenosylmethionine (AdoMet) as a cofactor and methyl donor for methyltransferase activity

  • Their endonucleolytic activity requires ATP, AdoMet, and Mg²⁺

  • They recognize asymmetric nucleotide sequences comprising two components (3-4 bp and 4-5 bp) separated by a nonspecific spacer of 6-8 bp

  • They methylate adenine residues, one in each component of the target sequence, but on opposite strands

  • When bound to an unmodified target sequence, they translocate (or pull) DNA toward themselves simultaneously in both directions in an ATP-dependent manner

For MPN_342, these characteristics would be expected if it functions as a canonical type I restriction enzyme, though specific recognition sequences and enzymatic parameters would need to be experimentally determined.

What are the best approaches for cloning and expressing recombinant MPN_342?

When cloning and expressing M. pneumoniae proteins like MPN_342, researchers must address several specific challenges:

  • Codon optimization: Mycoplasma species use the UGA codon to encode tryptophan rather than as a stop codon. This genetic code difference requires site-directed mutagenesis to change TGA codons to TGG before expression in E. coli systems .

  • PCR-based mutagenesis protocol:

    • Perform two separate PCRs (one with primers pET-Fw and Mutation-Rv, another with primers Mutation-Fw and pET-Rv)

    • Mix the products and subject them to a third PCR with primers pET-Fw and pET-Rv

    • Digest the resulting PCR product with appropriate restriction enzymes (e.g., NdeI and BamHI)

    • Ligate into compatible expression vectors such as pET-11c or pET-16b

  • Expression considerations: Use E. coli strains optimized for recombinant protein expression with careful monitoring of induction conditions to avoid formation of inclusion bodies.

  • Purification strategy: For type I restriction enzymes, consider affinity tags that won't interfere with enzymatic activity, followed by ion exchange and size exclusion chromatography steps.

What assays are most effective for characterizing MPN_342 enzymatic activity?

To characterize the enzymatic activities of MPN_342 as a putative type I restriction enzyme, researchers should implement multiple complementary assays:

Table 1: Enzymatic Activity Assays for MPN_342 Characterization

Assay TypeMethodologyExpected OutcomesKey Controls
DNA BindingElectrophoretic mobility shift assay (EMSA)Shifted DNA bands indicating protein-DNA complex formationCompetitor DNA, non-specific DNA sequences
Methyltransferase ActivityIncorporation of radiolabeled methyl groups from AdoMetProtection of DNA from subsequent restriction digestionPre-methylated DNA, AdoMet-free reactions
Endonuclease ActivityRestriction digestion of unmethylated DNADNA fragmentation patterns at variable distances from recognition siteMethylated DNA, ATP-free reactions
ATP HydrolysisColorimetric phosphate release assaysIncreased ATP hydrolysis in presence of DNANo-DNA controls, non-hydrolyzable ATP analogs
DNA TranslocationSingle-molecule DNA stretching assaysATP-dependent DNA movementATP-deficient conditions

Each assay should be performed under various conditions (pH, temperature, ionic strength) to determine optimal parameters for MPN_342 activity. Additionally, researchers should compare activities in the presence of various cofactors reported for type I restriction enzymes (ATP, AdoMet, Mg²⁺) .

How can mixed-methods approaches enhance research on MPN_342?

Mixed-methods approaches combine quantitative and qualitative methodologies to provide comprehensive insights into complex biological systems. For MPN_342 research, this integration can be particularly valuable:

  • Complementary strengths: Quantitative methods can provide precise measurements of enzymatic parameters, while qualitative methods can explore structural features and contextual functions .

  • Sequential explanatory design: Initial quantitative biochemical characterization followed by qualitative investigation of cellular effects or protein interactions .

  • Implementation framework:

    • Begin with quantitative enzyme kinetics and activity measurements

    • Follow with qualitative structural analyses (e.g., crystallography)

    • Integrate findings through computational modeling

    • Validate models with additional quantitative experiments

  • Holistic understanding: Mixed-methods research offers insights into different components of MPN_342 function that might help generate substantive theories about its role in M. pneumoniae biology .

This approach overcomes epistemological differences between quantitative and qualitative paradigms and provides a more complete understanding of MPN_342's biological significance .

How might MPN_342 contribute to M. pneumoniae pathogenicity?

While M. pneumoniae is not known to produce classical toxins, recent research has identified virulence factors like MPN372 that possess ADP-ribosyltransferase activity and can cause cellular damage . MPN_342, as a putative restriction enzyme, may contribute to pathogenicity through several mechanisms:

  • Genome protection: By restricting foreign DNA, MPN_342 may help protect the M. pneumoniae genome during infection, enabling bacterial persistence.

  • Regulation of horizontal gene transfer: Restriction-modification systems can influence the acquisition of virulence genes, potentially affecting pathogenicity.

  • Possible moonlighting functions: Similar to other bacterial enzymes, MPN_342 might have secondary functions beyond DNA restriction that directly contribute to host cell interactions.

  • Immune response modulation: The high immunogenicity observed for some M. pneumoniae proteins raises the possibility that MPN_342 might also elicit host immune responses during infection.

To investigate these possibilities, researchers could compare wild-type M. pneumoniae with MPN_342 knockout strains in infection models, analyzing differences in colonization, persistence, and host cell damage.

What optimal experimental design strategies should be employed for studying MPN_342 interactions?

Optimal experimental design for studying MPN_342 protein interactions should leverage principles of mutual information and submodularity . This approach ensures efficient exploration of the complex parameter space:

  • Mutual information maximization: Design experiments that maximize information gain about MPN_342 interactions with other proteins or DNA substrates .

  • Submodularity-based approach: Exploit the diminishing returns property of information gain to efficiently select the most informative experiments from a large possible set .

  • Model correction strategy: Implement experimental designs that can identify and correct misspecifications in the initial model of MPN_342 function .

Table 2: Experimental Design Framework for MPN_342 Interaction Studies

Design PhaseKey ConsiderationsMethodsExpected Outcomes
PlanningClear objectives, statistical power, randomizationPower analysis, factorial designOptimized experimental parameters
Initial ScreeningBroad exploration of potential interactionsYeast two-hybrid, pull-down assaysCandidate interaction partners
ValidationConfirmation of initial findingsCo-immunoprecipitation, FRETVerified protein-protein interactions
CharacterizationDetailed analysis of confirmed interactionsSPR, ITC, structural studiesBinding parameters, interaction interfaces
System IntegrationPlacing interactions in biological contextNetwork analysis, functional assaysBiological significance of interactions

This methodical approach maximizes information gain while minimizing experimental resources, particularly important for studying complex molecular machines like type I restriction enzymes .

How do type I restriction enzymes like MPN_342 differentiate between host and foreign DNA?

Type I restriction enzymes employ sophisticated mechanisms to distinguish between host and foreign DNA:

  • Methylation patterns: These enzymes recognize specific adenine residues in their target sequences. Host DNA typically contains methylated adenines (one in each component of the recognition sequence, but on opposite strands), while foreign DNA lacks this modification .

  • Dual functionality: The same enzyme complex can function either as a methyltransferase (when encountering hemimethylated DNA during replication) or as an endonuclease (when encountering unmethylated foreign DNA) .

  • Conformational changes: The methylation state of the target sequence triggers conformational changes in the enzyme complex, determining whether it performs methylation or restriction activity.

  • ATP-dependent DNA translocation: When bound to unmethylated DNA, the enzyme uses ATP to pull DNA toward itself in both directions simultaneously before cleaving at sites distant from the recognition sequence .

For MPN_342 specifically, researchers should determine its recognition sequence and methylation preferences through systematic DNA binding and cleavage assays using substrates with varying methylation patterns.

What challenges might researchers encounter when interpreting MPN_342 functional data?

Researchers studying MPN_342 may face several interpretational challenges:

  • Genetic code differences: The unusual genetic code of Mycoplasma (where UGA encodes tryptophan) can lead to expression difficulties and misinterpretation of sequence data .

  • Minimal genome context: M. pneumoniae's minimal genome means proteins often serve multiple functions, complicating interpretation of phenotypic data from genetic manipulations.

  • Complex enzymatic activities: Type I restriction enzymes possess multiple activities (DNA binding, ATP hydrolysis, methyltransferase, and endonuclease), making it challenging to disentangle specific functional defects in mutant proteins.

  • Limited homology: Low sequence conservation among restriction enzymes can make structural and functional predictions difficult.

  • Heterogeneity in research methodologies: Different laboratories may use varying experimental approaches, leading to apparently contradictory results .

How can researchers effectively integrate multiple data types when studying MPN_342?

Effective integration of diverse data types requires systematic approaches that acknowledge the strengths and limitations of each methodology:

Table 3: Data Integration Framework for MPN_342 Research

Data TypeKey ParametersIntegration StrategyValidation Approach
BiochemicalKinetic constants, cofactor requirementsCorrelation with structural featuresMutational analysis
StructuralDomain organization, active sitesMapping of functional data to structureMolecular dynamics
GeneticPhenotypes of mutants/knockoutsCorrelation with biochemical defectsComplementation studies
CellularLocalization, interaction partnersNetwork analysisCo-localization studies
EvolutionaryConservation patternsStructure-function correlationsComparative biochemistry

What are the most promising approaches for studying MPN_342's role in M. pneumoniae biology?

Future research on MPN_342 should focus on several promising directions:

  • Structural biology: Determining high-resolution structures through X-ray crystallography or cryo-EM would provide crucial insights into MPN_342's mechanism of action and potential for therapeutic targeting.

  • Systems biology: Placing MPN_342 within the broader context of M. pneumoniae's DNA metabolism network would clarify its role in maintaining genome integrity in this minimal organism.

  • Comparative genomics: Analyzing the conservation and variation of MPN_342 across different Mycoplasma species could reveal evolutionary adaptations and species-specific functions.

  • Host-pathogen interactions: Investigating whether MPN_342 interacts with host cellular components during infection, potentially contributing to pathogenicity beyond its canonical restriction function.

  • Therapeutic targeting: Exploring MPN_342 as a potential target for antimicrobial development, given the rising antibiotic resistance in M. pneumoniae infections.

Each of these directions would benefit from the optimal experimental design principles discussed earlier, maximizing information gain while minimizing resource expenditure .

How might research on MPN_342 contribute to understanding minimal genome organisms?

M. pneumoniae, with its reduced genome, serves as a model organism for understanding minimal cellular systems. Research on MPN_342 could provide valuable insights into several aspects of minimal genome biology:

  • Multifunctional proteins: Determining whether MPN_342 performs additional functions beyond restriction-modification would illustrate how minimal genome organisms maximize protein utility.

  • Essential DNA metabolism: Clarifying how M. pneumoniae maintains genomic integrity with a limited set of DNA repair and recombination proteins (~11 proteins) compared to more complex organisms.

  • Evolutionary trade-offs: Understanding what specific adaptations in MPN_342 function might compensate for the absence of other DNA metabolism proteins present in larger genomes.

  • Minimal functional requirements: Identifying the core domains and activities of MPN_342 that are conserved across multiple minimal genome organisms could reveal the essential features of restriction-modification systems.

  • Synthetic biology applications: Insights from MPN_342 could inform the design of minimal restriction-modification systems for synthetic biology applications, contributing to the development of engineered minimal cells.

Through careful experimental design and mixed-methods approaches , research on MPN_342 can advance our understanding of both specific restriction-modification mechanisms and broader principles of minimal genome organization and function.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.